FTox-G50-induced insulin resistance in skeletal muscle was not abolished by anti-TNF-α treatment and Map4k4 expression was not activated in skeletal muscle of mice injected with FTox-G50 (Figure 8B). The gene discussed is MAP4K4; the disease is Insulin resistance.